The Association of State and Territorial Health Officials (ASTHO), a US non-profit organisation, has requested the Administration and Congress to provide $1bn emergency supplemental funding to address opioid epidemic in the country.

The funding is intended to enable the Centres for Disease Control and Prevention (CDC), along with state and territorial health departments to allocate required resources.

Discover B2B Marketing That Performs

Combine business intelligence and editorial excellence to reach engaged professionals across 36 leading media platforms.

Find out more

In addition to boosting prevention campaigns for opioid misuse and addiction, the organisations plan to enhance public health surveillance for gaining better insights on the epidemic.

The fund will also be utilised to link electronic health records with prescription drug monitoring programmes (PDMPs), as well as for expansion of access to naloxone, medication assisted treatment and additional services such as telehealth and telemedicine.

“While the Administration has made major federal investments in treatment and recovery, health officials need funding for prevention.”

Furthermore, the agencies intend to expand partnerships with law enforcement.

ASTHO executive director Michael Fraser said: “While the Administration has made major federal investments in treatment and recovery, health officials need funding for prevention.

GlobalData Strategic Intelligence

US Tariffs are shifting - will you react or anticipate?

Don’t let policy changes catch you off guard. Stay proactive with real-time data and expert analysis.

By GlobalData

“We strongly encourage Congress to provide this emergency supplemental funding and address this deadly crisis like any other emergency where the Administration proposes and Congress provides the resources necessary to defeat it.”

According to ASTHO, more population-based and community-wide public health programmes will be required to address the opioid misuse.

When granted, the emergency supplemental funding will be spent during fiscal 2018 and 2019 by the CDC, and state and territorial health departments to prevent use of illicit substances, primarily opioid.

Pharmaceutical Technology Excellence Awards - The Benefits of Entering

Gain the recognition you deserve! The Pharmaceutical Technology Excellence Awards celebrate innovation, leadership, and impact. By entering, you showcase your achievements, elevate your industry profile, and position yourself among top leaders driving pharmaceutical advancements. Don’t miss your chance to stand out—submit your entry today!

Nominate Now